Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,790.09 +1,480.20 (+2.27%) CMC Crypto 200
1,364.66 -9.18 (-0.67%)
TriSalus Life Sciences, Inc. (TLSI)
| Previous close | 9.70 |
| Open | 9.58 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 9.52 - 9.88 |
| 52-week range | 3.32 - 12.83 |
| Volume | |
| Avg. volume | 41,088 |
| Market cap | 296.468M |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.73 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 16.00 |
Business WireTriSalus Reports Q1 2024 Financial Results and Business Update
DENVER, May 15, 2024--TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced its financial results for the first quarter ended March 31, 2024, and provided a business update.
Business WireTriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors
DENVER, May 07, 2024--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced today the appointment of Liselotte Hyveled to its Board of Directors. Ms. Hyveled brings over two decades of experience stimulating scientific innovation and advancing pharmaceutical pipelines through research and development excellence.
Business WireTriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call
DENVER, May 06, 2024--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, announced today it will host a conference call and webcast on May 15, 2024, at 9:00 a.m. ET to discuss financial results for the first quarter ended March 31, 2024, and provide a business update. A press release detailing the first quarter results will be issued prior to the call.
